AIM
JAZZ icon

Assured Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Assured Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-31,226
Closed -$4.46M – 438
2019
Q1 		$4.46M Sell
31,226
-4,595
-13% -$599K 0.05% 165
2018
Q4 		$4.44M Buy
35,821
+14,894
+71% +$2.21M 0.13% 210
2018
Q3 		$3.52M Sell
20,927
-6,304
-23% -$1.08M 0.06% 330
2018
Q2 		$4.69M Sell
27,231
-22,588
-45% -$3.69M 0.09% 255
2018
Q1 		$7.52M Sell
49,819
-18,198
-27% -$2.67M 0.17% 155
2017
Q4 		$9.16M Buy
+68,017
New +$9.43M 0.18% 112
2017
Q3 		– Sell
-6,696
Closed -$1.04M – 647
2017
Q2 		$1.04M Buy
+6,696
New +$1.02M 0.02% 385
2017
Q1 		– Sell
-3,475
Closed -$379K – 660
2016
Q4 		$379K Sell
3,475
-5,311
-60% -$592K 0.01% 463
2016
Q3 		$1.07M Buy
8,786
+3,187
+57% +$430K 0.02% 294
2016
Q2 		$791K Sell
5,599
-1,618
-22% -$239K 0.02% 312
2016
Q1 		$942K Buy
7,217
+3,039
+73% +$378K 0.02% 202
2015
Q4 		$587K Sell
4,178
-209
-5% -$29K 0.01% 267
2015
Q3 		$583K Buy
4,387
+1,155
+36% +$199K 0.01% 332
2015
Q2 		$569K Buy
+3,232
New +$580K 0.01% 336

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Assured Investment Management's JAZZ Position: Q2 2019 in Review

Assured Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2019, closing a stake of 31,226 shares — an estimated $4.46M sold.

Assured Investment Management first reported a position in JAZZ in Q2 2015 and held it in 14 quarters. The position peaked at $9.16M in Q4 2017. 416 funds tracked by Wall St. Rank hold JAZZ as of Q2 2019.

  • Assured Investment Management reported no remaining Jazz Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 31,226 Jazz Pharmaceuticals shares in Q2 2019, an estimated $4.46M.
  • Assured Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2015 and held it in 14 quarters.
  • Assured Investment Management's Jazz Pharmaceuticals position peaked at $9.16M in Q4 2017.
  • 416 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.